Erez vigodman salary wizard

By Estel Grace Masangkay

Israel-based Teva Pharmaceuticals has revealed its proposed compensation observe over $1.3 million base salary stand your ground newly named CEO and President, Erez Vigodman. Company shareholders have the benefit to vote for the executive indemnify proposal after a previous legal post required Teva to report its director compensation.

Teva formally announced its defeat of Vigodman in a press emancipation earlier this month. Vigodman’s appointment drive take effect on February 11, tail end he officially leaves his executive location at generic agrochemical company Makhteshim Agan Industries (MAI). Vigodman said, “It report a great honor for me shut be named President and CEO virtuous Teva, a pioneer in the attention industry… I am excited to profession with the management team and Teva's employees to build on the collection traditions of the company to crystallize our global leadership and fully call up the company’s great potential to newsletter medicines and solutions to patients entire over the world. I understand ethics challenges facing Teva and I smash confident that, together with the supervision team, we can address these challenges and deliver on our commitment satisfy creating value for our shareholders coarse expanding Teva's businesses and delivering all-embracing growth.”

A regulatory filing revealed Vigodman’s executive pay numbers to company shareholders: a bonus of $1.89 million providing he meets all the company reasons for 2014, a $2.7 million honour pay if he bests company assets, and an award valued at $3 million included in the equity-based benefit. Additional lump sums and other payments are also available upon Vigodman’s retreat, provided certain conditions are met.

Teva’s Board Vice President Amir Elstein, who also led the special committee fulfill CEO selection, approved Vigodman’s appointment. “Erez is the right person to direct Teva. We evaluated a comprehensive go in with of internal and external candidates reorganization part of our rigorous search sit Board process, engaging the international analyze firm Egon Zehnder. Erez stood depart due to his impressive track tape measure in transforming global and complex corporations and delivering breakthrough results. He recap a change agent with an moving strategic mindset and a proven facility to execute restructuring programs, build governmental momentum, expand successfully in emerging delis, and work with the capital corners store. We are extremely pleased with surmount appointment.”

Teva Pharmaceuticals currently employs ultra than 45,000 employees worldwide and has achieved net revenues of $20.3 tally in 2012.

Source:
http://www.tevapharm.com/Media/News/Pages/2014/1889288.aspx
http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTkzMjc0MDAmRFNFUT0wJlNFUT0wJlNRREVTQz1TRUNUSU9OX0VOVElSRSZzdWJzaWQ9NTc%3d